Postoperative Adjuvant TACE Treatment in CK18 Positive Patients

To evaluate and analyse the clinical effect and application value of postoperative adjuvant TACE treatment in patients with different expression levels of CK18 using randomized controlled study and provide evidence for the necessity of postoperative adjuvant TACE.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postoperative Adjuvant TACE Adenocarcinoma Carcinoma Carcinoma, Hepatocellular Digestive System Diseases Digestive System Neoplasms Hepatocellular Carcinoma. Liver Diseases Liver Neoplasms Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Eastern hepatobilliary surgery hospital

Shanghai, Shanghai Municipality, 200438, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Via clinical diagnosis and confirm it is primary liver cancer
Pathological evidence of HCC
Estimate tumor can gain treatment of curing operation
No evidence for extrahepatic metestasis
liver function ：Child-Pugh A/B

Exclusion criteria

reject to attend；
impossible to come to our hospital for physical examination regularly.
cancer epitome、seed focus、lymph node or distant metastasis
Blood clotting function hindrance; 5, Patients with other diseases which may affect the treatment mentioned.

Treatment and study plan

Primary outcomes

Overall survival

Time frame: 3 years

Secondary outcomes

Time to recurrence

Time frame: 3 years

Sponsors and collaborators

Lead sponsor

Eastern Hepatobiliary Surgery Hospital

Other

Registry information

Official study title

The Effect of Postoperative Adjuvant TACE Treatment in CK18 Positive Patients of Hepatocellular Carcinoma.

Important dates

Study start: 2013
Primary completion: 2015
Study completion: 2015
First posted: Mar 31, 2016
Registry last updated: Mar 31, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed